Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chardack, W. M.
Right arrow Articles by Greatbatch, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chardack, W. M.
Right arrow Articles by Greatbatch, W.
(Chest. 1963;43:225-239.)
© 1963 American College of Chest Physicians

Two Years' Clinical Experience with the Implantable Pacemaker for Complete Heart Block

William M. Chardack M.D.1; Andrew A. Gage M.D.1; George Schimert M.D.1; Norman B. Thomson M.D., F.C.C.P.1; Clarence E. Sanford M.D.1; and Wilson Greatbatch M.S.1

1 Department of Surgery, University of Buffalo School of Medicine and the Surgical Services. Veterans Administration Hospital, E. J. Meyer Memorial Hospital, Children's Hospital of Buffalo, Millard Fillmore Hospital, and Buffalo General Hospital

1. A subcutaneously implanted electronic prosthesis was used in 42 patients for the correction of complete heart block.

2. A total mortality of eight cases has occurred, with four deaths within 20 days of operation. Of four late deaths, three were due to intrinsic myocardial disease and one presumably related to intermittent pacemaker function.

3. The 34 surviving patients are currently pacemade and rehabilitated with a follow-up varying from one to 25 months and a mean follow-up of 11.5 months.

4. The complications and difficulties seen in the early phase of this clinical experience were chiefly caused by the mechanical breakdown of the electrode then in use. The mechanical and electrical stability of the platinum-iridium coil electrode used in the last 26 patients has been satisfactory, without exception.

5. Recent improvements in the design of the implanted pacemaker have been described. These include a reduction in size, and addition of rate and amplitude controls which can be actuated by the physician by a simple percutaneous puncture.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1963 by the American College of Chest Physicians.